Acute LPS sensitization and continuous infusion exacerbates hypoxic brain injury in a piglet model of neonatal encephalopathy.
Kathryn A MartinelloChristopher MeehanAdnan Avdic-BelltheusIngran LingamSara RagabMariya HristovaCally J TannDonald PeeblesHenrik HagbergTim G A M WolfsNigel KleinIlias TachtsidisXavier GolayBoris W KramerBobbi FleissPierre GressensNicola J RobertsonPublished in: Scientific reports (2019)
Co-existing infection/inflammation and birth asphyxia potentiate the risk of developing neonatal encephalopathy (NE) and adverse outcome. In a newborn piglet model we assessed the effect of E. coli lipopolysaccharide (LPS) infusion started 4 h prior to and continued for 48 h after hypoxia on brain cell death and systemic haematological changes compared to LPS and hypoxia alone. LPS sensitized hypoxia resulted in an increase in mortality and in brain cell death (TUNEL positive cells) throughout the whole brain, and in the internal capsule, periventricular white matter and sensorimotor cortex. LPS alone did not increase brain cell death at 48 h, despite evidence of neuroinflammation, including the greatest increases in microglial proliferation, reactive astrocytosis and cleavage of caspase-3. LPS exposure caused splenic hypertrophy and platelet count suppression. The combination of LPS and hypoxia resulted in the highest and most sustained systemic white cell count increase. These findings highlight the significant contribution of acute inflammation sensitization prior to an asphyxial insult on NE illness severity.
Keyphrases
- inflammatory response
- cell death
- white matter
- anti inflammatory
- brain injury
- cell cycle arrest
- lps induced
- resting state
- cerebral ischemia
- lipopolysaccharide induced
- functional connectivity
- induced apoptosis
- oxidative stress
- liver failure
- toll like receptor
- endothelial cells
- subarachnoid hemorrhage
- low dose
- signaling pathway
- escherichia coli
- early onset
- drug induced
- peripheral blood
- cardiovascular disease
- emergency department
- single cell
- pregnant women
- immune response
- mesenchymal stem cells
- neuropathic pain
- cognitive impairment
- bone marrow